Indivior share price logo

Indivior

NASDAQ: INDV

$34.87

-0.43

(-1.22%)

as on

Indivior Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $34.49
    $35.49
    downward going graph

    1.09%

    Downside

    1.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $22.22
    $42.81
    downward going graph

    36.28%

    Downside

    22.77%

    Upside

    downward going graph

Indivior share price movements today

Previous Close
$35.30
Open
$35.23
Volume
2.0M
Market Cap
$4.3B
Day's Low - High
$34.49 - $35.49
52 Week Low - High
$22.22 - $42.81

Indivior Historical Returns

1 Month Return
-13.88 %
3 Month Return
-3.58 %
1 Year Return
+ 47.82 %
3 Year Return
+ 56.68 %
5 Year Return
0 %

Indivior Stock Fundamentals & Key Indicators

Check Indivior market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.3B

EPS (TTM)

4.4087

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

6.00%

PE Ratio (TTM)

12.84

Industry PE ratio

27.681538461538462

PEG Ratio

0

EBITDA

576.0M

Revenue (TTM)

1.3B

Profit Margin

26.75%

Return On Equity TTM

12.20%

Indivior Stock Valuation

Track how Indivior P/E has moved over time to understand its valuation trends.

Indivior in the last 5 years

  • Overview

  • Trends

Lowest (-108.16x)

September 30, 2023

Today (12.84x)

August 28, 2026

Industry (27.68x)

August 28, 2026

Highest (12.41x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 12.84x

Indivior vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indivior with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Indivior image
Indivior
BUY$4.3BNA12.8426.75%NA
United Therapeutics image
United Therapeutics
BUY$22.6B150.1%16.5886.14%NA
Viatris image
Viatris
HOLD$19.2B17.54%-46.4434.83%2.87%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$44.4BNA20.7614.55%121.78%
Zoetis image
Zoetis
BUY$31.9B-63.19%12.4770.87%2.76%
See all

Stock Returns calculator for Indivior Stock including INR - Dollar returns

The Indivior stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Indivior investment value today

Current value as on today

₹1,58,266

Returns

₹58,266

(+58.27%)

Returns from Indivior Stock

₹46,022 (+46.02%)

Dollar Impact

₹12,244 (+12.24%)

Analyst Recommendation on Indivior Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Indivior. Average target price of $49

Indivior Share Price Target

Get share price movements and forecasts by analysts on Indivior.

What analysts predicted

28.84%UPSIDE

Target Price

$49

Current Price

$34.87

Analyzed by

3 Analysts

Target

$49.00

Indivior target price $49, a slight upside of 28.84% compared to current price of $34.87. According to 3 analysts rating.

Indian Investors' Interest in Indivior Stock

Search interest for Indivior Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

Indivior Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
284
299
307
299
266
302
314
358
316
343
Gross Profit
246
220
238
276
222
250
252
294
276
294
Operating Income
75
-118
4
96
66
72
99
122
137
160
EBITDA
87
-106
22
106
76
82
54
92
123
162
Interest Expense
8
9
10
13
12
15
12
6
6
2
Depreciation
9
25
-10
5
5
5
5
5
4
3
Income Before Tax
73
-121
-1
88
59
62
37
81
115
160
Income Tax Expense
11
-23
-5
28
11
44
-5
-21
25
38
Net Income
61
-97
4
59
47
18
42
102
88
122
Net Profit Margin
21.48%
-32.44%
1.30%
19.73%
17.67%
5.96%
13.38%
28.49%
28.08%
35.57%

Indivior Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
968
1,148
959
785
647
791
901
1,093
1,188
1,239
Gross Profit
858
1,025
825
645
550
664
750
919
957
993
Operating Income
337
423
317
178
-156
213
-81
-156
32
265
EBITDA
149
436
310
230
-123
238
-46
-99
84
304
Interest Expense
51
49
31
22
24
26
29
35
41
45
Depreciation
-
-
-
28
26
22
21
28
29
20
Income Before Tax
89
143
265
180
-173
190
-89
-149
14
239
Income Tax Expense
57
82
2
46
-25
-15
-44
-20
11
29
Net Income
32
60
262
134
-148
205
-44
-129
2
210
Net Profit Margin
3.31%
5.31%
27.36%
17.07%
-22.87%
25.92%
-4.88%
-11.80%
0.17%
16.95%

Indivior Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-97
22
66
47
18
43
102
89
122
Operating Cash Flow
88
2
-5
75
158
-39
-221
-9
229
Investing Cash Flow
1
35
10
-5
-17
-20
-24
-19
-8
Financing Cash Flow
-35
-51
27
-17
-5
-3
-5
7
-173
Change in Cash
54
-14
31
53
137
-64
-250
-20
48

Indivior Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
193
292
178
-156
213
-44
-126
7
210
Operating Cash Flow
295
303
151
-193
353
-4
-300
36
-27
Investing Cash Flow
-43
-4
-2
-4
-14
-222
-95
69
-66
Financing Cash Flow
-84
-237
-13
-10
-94
-101
-64
-102
-30
Change in Cash
171
61
136
-202
244
-328
-458
3
-124

Mutual Funds that own Indivior Stock

Check out the Mutual Funds with significant holdings in Indivior.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
8.351991%
9856490
Capitol Series Trust
2.828112%
3337559
Fidelity Salem Street Trust
1.117252%
1318511
Fidelity Concord Street Trust
1.058325%
1248968
DFA INVESTMENT DIMENSIONS GROUP INC
0.836133%
986752
See all

Global Institutional Holdings in Indivior

Funds
Holdings
iShares
11.95%
Vanguard
9.8%
SPDR
2.19%
Richard Driehaus
1.95%
Invesco
1.63%
See all

Indivior News & Key Events

  • img

    Today's Timeline - 23 June

    Tue, 08:37 PM

    -

    Indivior Pharmaceuticals sees EPS estimates rise for 2026 and 2027, with shares up 6.8% year to date.

Insights on Indivior

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 316.99M → 342.99M (in $), with an average increase of 7.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 88.99M → 121.99M (in $), with an average increase of 27.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation Common Stock has given 69.1% return, outperforming this stock by 25.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 125.6% return, outperforming this stock by 73.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INDV stock has moved down by -5.4%

About Indivior

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
OrganisationIndivior
Headquarters10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Joseph J. Ciaffoni
E-voting on sharesClick here to vote

Key Management of Indivior

Name

Title

Mr. Kevin L. Espinoza

Chief Integrity & Compliance Officer

Ms. Angela Colon-Mahoney M.S.

Chief Human Resources Officer

Ms. Vanessa Procter

Executive Vice President of Corporate Affairs

Mr. Joseph J. Ciaffoni

CEO & Director

Dr. Christian Heidbreder

Chief Scientific Officer

Mr. Jeffrey W. Burris J.D.

Chief Legal Officer

Mr. Patrick a. Barry

Chief Commercial Officer

Mr. Jason Thompson

Vice President of Investor Relations

Dr. Ann Wheeler Pharm.D.

Chief Medical Officer

Mr. Ryan Preblick

Chief Financial Officer

FAQs

What is Indivior share price today?

Indivior share price today is $34.87 as on at the close of the market. Indivior share today touched a day high of $35.49 and a low of $34.49.

What is the 52 week high and 52 week low for Indivior share?

Indivior share touched a 52 week high of $42.81 on and a 52 week low of $22.22 on . Indivior stock price today i.e. is closed at $34.87,which is 18.55% down from its 52 week high and 56.93% up from its 52 week low.

What is Indivior's market capitalisation today?

Indivior market capitalisation is $0.00T as on .

How to invest in Indivior Stock (INDV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Indivior on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indivior Shares that will get you 0.0430 shares as per Indivior share price of $34.87 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Indivior Stock (INDV) from India?

Indian investors can start investing in Indivior (INDV) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Indivior stock (as per the Rupee-Dollar exchange rate as on ). Based on Indivior share’s latest price of $34.87 as on August 29, 2026 at 8:46 am IST, you will get 0.2868 shares of Indivior. Learn more about fractional shares .